Longitudinal associations of serum MCP-1 with cognitive decline and psychological stress in biomarker-confirmed Alzheimer's disease: A pilot study
Fumihiko Yasuno, Yasuyuki Kimura, Yumeka Yamauchi, Hiroyuki Minami, Kensaku Kasuga, Takeshi Ikeuchi, Akinori Takeda, Takashi Sakurai · 2026
Read Longitudinal associations of serum MCP-1 with cognitive decline and psychological stress in biomarker-confirmed Alzheimer's disease: A pilot study by Fumihiko Yasuno, Yasuyuki Kimura, Yumeka Yamauchi, Hiroyuki Minami, Kensaku Kasuga, Takeshi Ikeuchi, Akinori Takeda, Takashi Sakurai (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13543105.txt.
Description
Eight researchers in Japan follow a blood marker in Alzheimer's disease in a 2026 pilot study. The marker, called MCP-1, plays a role in swelling in the brain. Past work links high levels to cell harm and to a weaker blood and brain barrier.
The study held 21 people whose tests confirmed the disease process, and it checked them again one year later. Changes in the marker over that year tracked with loss of thinking skills. Stress scores also rose and fell with the marker. The authors treat the work as a first step and note the small group size limits what can be claimed.
Catalog record
| CREATOR | Fumihiko Yasuno, Yasuyuki Kimura, Yumeka Yamauchi, Hiroyuki Minami, Kensaku Kasuga, Takeshi Ikeuchi, Akinori Takeda, Takashi Sakurai |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |